Not exact matches
A second set of experiments, in which a second heart was grafted roughly a month after
rejection to give potential
immune memory more time to develop, showed similar long -
term acceptance.
The
immune rejection that complicates organ transplants, and normally requires long -
term immunosuppressive drug therapy, may also be treatable with CAAR T cell technology.
In theory, the developing fetus with an immature
immune system should be a prime target for successful transplantation, since the risk of graft
rejection is low and the need for long -
term immunosuppressive therapy may be avoided.